Article lists

Output options Results per page:
Start with result #
Primary sort by
Secondary sort by
Note: sorting is done relative to the first project.
Release / review data Filter release / review data
Review status
Release status
Category filter Filter by category
Article category:
Talk category:

 
Result Article Importance Quality Review
Release Shows whether this article has been reviewed as a featured article or good article, and whether the article has been included in a release version of Wikipedia.
Score This number is used to automatically select articles for release versions of Wikipedia.
1 Cholangiocarcinoma (t · h · l) Mid 2011-11-29 (t FA 2011-11-29 (t FA 1265
2 Chronic myelomonocytic leukemia (t · h · l) Mid 2011-05-10 (t B 2013-04-07 (t 753
3 Medullary thyroid cancer (t · h · l) Mid 2011-04-30 (t B 2011-04-30 (t 896
4 Seminoma (t · h · l) Mid 2011-12-03 (t B 2011-12-03 (t 1024
5 Thrombotic thrombocytopenic purpura (t · h · l) Mid 2013-01-12 (t B 2013-08-21 (t 1122
6 Cancer systems biology (t · h · l) Mid 2013-05-21 (t C 2013-05-21 (t 425
7 Ductal carcinoma in situ (t · h · l) Mid 2014-06-19 (t C 2014-06-19 (t 425
8 Erythropoiesis (t · h · l) Mid 2012-07-30 (t C 2012-07-30 (t 1064
9 Giant-cell carcinoma of the lung (t · h · l) Mid 2012-06-13 (t C 2012-06-13 (t 425
10 Gleason Grading System (t · h · l) Mid 2012-12-31 (t C 2013-02-26 (t 943
11 HPV-positive oropharyngeal cancer (t · h · l) Mid 2011-04-03 (t C 2011-04-03 (t 634
12 Ivor Royston (t · h · l) Mid 2014-04-29 (t C 2014-04-29 (t 542
13 Jack Andraka (t · h · l) Mid 2013-02-24 (t C 2013-02-12 (t 425
14 Penile cancer (t · h · l) Mid 2011-12-02 (t C 2011-12-02 (t 425
15 Schilling test (t · h · l) Mid 2013-01-29 (t C 2013-01-29 (t 913
16 Acinar adenocarcinoma (t · h · l) Mid 2012-06-18 (t Start 2012-06-18 (t 365
17 Anaplastic carcinoma (t · h · l) Mid 2012-06-18 (t Start 2012-06-18 (t 373
18 Basaloid large cell carcinoma of the lung (t · h · l) Mid 2012-06-13 (t Start 2012-06-13 (t 350
19 Beta thalassemia (t · h · l) Mid 2011-01-28 (t Start 2011-01-28 (t 350
20 Bloodless surgery (t · h · l) Mid 2010-05-28 (t Start 2010-05-28 (t 693
21 Exchange transfusion (t · h · l) Mid 2013-07-20 (t Start 2013-07-20 (t 695
22 Heinz body (t · h · l) Mid 2012-12-31 (t Start 2012-12-31 (t 753
23 Hyper-CVAD (t · h · l) Mid 2011-05-09 (t Start 2013-11-07 (t 350
24 Leukostasis (t · h · l) Mid 2013-01-27 (t Start 2013-01-27 (t 402
25 Nodular lymphocyte predominant Hodgkin's lymphoma (t · h · l) Mid 2013-01-26 (t Start 2013-01-26 (t 605
26 Normocytic anemia (t · h · l) Mid 2011-04-07 (t Start 2011-04-07 (t 732
27 Optic nerve tumor (t · h · l) Mid 2013-01-29 (t Start 2013-08-09 (t 384
28 Poikilocytosis (t · h · l) Mid 2013-01-29 (t Start 2013-01-29 (t 863
29 Pott's puffy tumor (t · h · l) Mid 2011-05-04 (t Start 2011-05-04 (t 453
30 Sticky platelet syndrome (t · h · l) Mid 2013-01-29 (t Start 2013-01-29 (t 392
31 Synovial sarcoma (t · h · l) Mid 2011-05-09 (t Start 2011-05-09 (t 785
32 Third-hand smoke (t · h · l) Mid 2011-06-06 (t Start 2010-12-07 (t 350
33 Transfusion associated circulatory overload (t · h · l) Mid 2011-05-25 (t Start 2011-05-25 (t 601
34 Triple-negative breast cancer (t · h · l) Mid 2011-06-06 (t Start 2011-06-06 (t 563
35 Acinic cell carcinoma of the lung (t · h · l) Mid 2012-06-18 (t Stub 2012-06-18 (t 334
36 Blastic NK cell lymphoma (t · h · l) Mid 2011-05-09 (t Stub 2011-05-09 (t 536
37 Blood lead level (t · h · l) Mid 2011-04-07 (t Stub 2011-06-14 (t 453
38 Bragg peak (t · h · l) Mid 2014-04-10 (t Stub 2014-04-10 (t 680
39 Carcinosarcoma (t · h · l) Mid 2011-07-09 (t Stub 2011-07-09 (t 552
40 Carcinosis (t · h · l) Mid 2011-05-10 (t Stub 2011-03-01 (t 541
41 Digestive system neoplasm (t · h · l) Mid 2013-01-26 (t Stub 2013-01-26 (t 596
42 Drug-induced autoimmune hemolytic anemia (t · h · l) Mid 2011-05-20 (t Stub 2011-05-20 (t 574
43 Drug-induced nonautoimmune hemolytic anemia (t · h · l) Mid 2011-05-20 (t Stub 2011-05-20 (t 567
44 Embryonal rhabdomyosarcoma (t · h · l) Mid 2011-04-17 (t Stub 2011-04-17 (t 526
45 Endocrine gland neoplasm (t · h · l) Mid 2013-01-26 (t Stub 2013-01-26 (t 601
46 Giant platelet disorder (t · h · l) Mid 2013-01-26 (t Stub 2013-01-26 (t 300
47 Glomangiosarcoma (t · h · l) Mid 2011-05-31 (t Stub 2011-05-31 (t 500
48 Growth factor receptor inhibitor (t · h · l) Mid 2013-10-18 (t Stub 2013-10-18 (t 300
49 Macroovalocyte (t · h · l) Mid 2012-11-11 (t Stub 2012-11-11 (t 347
50 Marginal zone B-cell (t · h · l) Mid 2013-01-29 (t Stub 2013-01-29 (t 576
51 Medullary carcinoma of the breast (t · h · l) Mid 2011-06-10 (t Stub 2011-06-10 (t 549
52 Microcytosis (t · h · l) Mid 2013-01-29 (t Stub 2013-01-29 (t 678
53 Myelodysplastic–myeloproliferative diseases (t · h · l) Mid 2014-06-07 (t Stub 2014-06-07 (t 300
54 Nodal marginal zone B cell lymphoma (t · h · l) Mid 2013-01-26 (t Stub 2013-08-09 (t 546
55 Papillary adenocarcinoma (t · h · l) Mid 2012-06-14 (t Stub 2012-06-14 (t 362
56 Poorly differentiated thyroid cancer (t · h · l) Mid 2012-11-11 (t Stub 2012-07-27 (t 300
57 Precursor B-cell lymphoblastic leukemia (t · h · l) Mid 2011-05-31 (t Stub 2011-05-31 (t 561
58 Precursor T-cell lymphoblastic leukemia (t · h · l) Mid 2013-01-29 (t Stub 2013-01-29 (t 573
59 Respiratory tract neoplasm (t · h · l) Mid 2013-01-26 (t Stub 2013-01-26 (t 561
60 Reticulocytosis (t · h · l) Mid 2011-06-06 (t Stub 2011-06-06 (t 685
61 Sarcomatoid carcinoma (t · h · l) Mid 2011-06-06 (t Stub 2011-06-06 (t 471
62 Sclerosing rhabdomyosarcoma (t · h · l) Mid 2011-06-06 (t Stub 2011-06-06 (t 300
63 Thrombohemorrhagic event (t · h · l) Mid 2013-01-26 (t Stub 2013-01-26 (t 315
64 Urogenital pelvic malignancy (t · h · l) Mid 2011-05-10 (t Stub 2011-05-10 (t 300
65 Treatment of rare lung cancers (t · h · l) Mid 2011-05-09 (t NA 2013-09-09 (t 282